| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ecebc54292ba538ce460b85feded62ec |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate |
2010-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2164f3e9397f9b4ee32fea4f4b91210
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8e2fc347562c9d7e835584634f660e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a1849c29cbcbeb3f304a740e3d776f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74e096c724c7eeadbbc750e149e9d182
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1019ab853e357646b2a80a5703102505 |
| publicationDate |
2021-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112012000101-B1 |
| titleOfInvention |
medicinal carbohydrates for the treatment of respiratory conditions |
| abstract |
medicinal carbohydrates for treating respiratory conditions the present invention relates to a method and compounds of formula (1) and / or (2) or the pharmaceutically acceptable inorganic or organic salts thereof, and their compositions for treating respiratory conditions comprising post viral infections / bacterial infections, acute / chronic bronchitis, copd, cystic fibrosis, and inflammatory conditions. it has been found by the inventors that the compounds of formula (1) and / or (2) or the inorganic or organic pharmaceutically acceptable salts thereof could accelerate the recovery of damaged respiratory tract cell viability by restoring sialyl-glycoconjugates on their surface. |
| priorityDate |
2009-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |